Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week

Dna, Genetic Material, Helix, Proteins, Biology

Image Source: Unsplash

An Introduction

This article highlights the 10 clinical-stage AI-powered (designated with *) and psychedelic compound-based (designated with **)  small cap ($400M to $2.0B) drug discovery companies in the munKNEE Clinical-Stage BioTech Drug Stocks Portfolio, their stock performances last week, in descending order, and MTD and their areas of focus, along with their latest news, analyses and commentary where available.

  1.  **GH Research (GHRS): UP 8.7% last week; UP 30.4% MTD
  2. *AbCellera Biologics (ABCL): UP 5.8% last week; UP 2.4% MTD
  3. *Relay Therapeutics (RLAY): UP 2.7% last week; UP 7.1% MTD
    • specializes in developing an artificial intelligence-driven allosteric drug-discovery platform intended to detect and characterize interactions that occur on a protein of interest and combines computational methods with experimental approaches across the fields of structural biology, biophysics, and chemistry. Its initial focus on precision oncology and genetic diseases.
    • Latest news, commentary and/or analysis:
  4. **Mind Medicine (MNMD): UP 0.1% last week; DOWN 3.4% MTD
  5. *Recursion Pharmaceuticals (RXRX): DOWN 2.8% last week; UP 12.8% MTD
  6. *Schrödinger (SDGR): DOWN 3.4% last week; DOWN 8.3% MTD
  7. **Compass Pathways (CMPS): DOWN 4.6% last week; DOWN 5.8% MTD
  8. **atai Life Sciences (ATAI): DOWN 5.8% last week; DOWN 16.6% MTD
  9. *Absci Corporation (ABSI): DOWN 8.9% last week; DOWN 8.1% MTD
  10. *Exscientia (EXAI): DOWN 9.8% last week; UP 16.4% MTD

Summary

On average, the above 10 stocks were DOWN 1.1% last week and are now DOWN 0.6% MTD and DOWN 11.7% YTD.


More By This Author:

AI Category Returns Were A Mixed Bag This Week
Update: Ai Pin Widely Panned; Humane Announces It's For Sale
These AI Stocks Have Momentum Up And Down

Disclosure: None

This article has been composed with the exclusive application of the human intelligence (HI) of the author. No artificial intelligence (AI) technology has been deployed. ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.